US Stocks
/
Gain Therapeutics, Inc. Share Price
Gain Therapeutics, Inc. Share Price

Gain Therapeutics, Inc. Share Price

NASDAQ: GANX | Micro Cap
$1.61
-$0.06 (-3.59%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Gain Therapeutics, Inc. Stock Performance

Open
$1.63
Prev. Close
$1.67
Circuit Range
N/A
Day Range
$1.61 - $1.64
Year Range
$1.54 - $4.33
Volume
5,263
Average Traded
$1.63

Gain Therapeutics, Inc. Share Price Today

As of 9 October 2026, Gain Therapeutics, Inc.'s share price is $1.61. The stock opened at $1.63, compared to its previous close of $1.67. During today's trading session, Gain Therapeutics, Inc.'s share price traded between $1.61 and $1.64, with an average price of $1.63. Over the past 52 weeks, the stock has recorded a high of $4.33 and a low of $1.54. In terms of performance, Gain Therapeutics, Inc.'s share price has declined by 14.81% over the last six months and is down 18.07% on a year-on-year basis.

Gain Therapeutics, Inc. Share Price Chart

$1.61$1.64
L
Show Current Price
H

Gain Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$53.08M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.46
Revenue (TTM)
$0.00
Return On Equity (TTM)
-178.06%
Profit Margin
N/A
Debt to Equity
0.03
Quarterly Earnings Growth YoY
11.36%

Gain Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$5.28-$4.54-$5.61-$4.68
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A14.02%-23.57%16.58%

Gain Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.13$0.06$0.00$0.00
Net Profit-$17.59-$22.27-$20.41-$20.16
Net Profit Margin-13530.77%-37116.67%N/AN/A
Income ChangeN/A-26.61%8.35%1.22%

About Gain Therapeutics, Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Gain Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.73
$1.62
-6.90%
Sep 2026
$1.81
$1.74
-6.20%
Aug 2026
$1.68
$1.85
+10.42%
Jul 2026
$2.04
$1.68
-17.20%
Jun 2026
$1.96
$2.03
+2.47%
May 2026
$1.83
$1.98
+4.76%
Apr 2026
$1.95
$1.89
-2.07%
Mar 2026
$2.54
$1.93
-26.05%
Feb 2026
$1.85
$2.61
+44.20%
Jan 2026
$3.20
$1.81
-43.88%
Dec 2025
$3.40
$3.23
-7.73%
Nov 2025
$1.99
$3.50
+77.86%

GANX Share Price FAQs

What is Gain Therapeutics, Inc. share price today?

chevron-up
Gain Therapeutics, Inc. share price today is $1.61 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Gain Therapeutics, Inc. stock?

chevron-up
The 52 week high of Gain Therapeutics, Inc. stock is $4.33, while the 52 week low is $1.54 as of 9 Oct '26.

What is GANX's market capitalisation today?

chevron-up
GANX market capitalisation is $53.08M as of October 9, 2026, at 4:49 pm IST.

What is GANX's net income for the last quarter?

chevron-up
GANX's net income for the last quarter is -4.68B USD.

What is the 5 year returns of GANX?

chevron-up
The 5 year returns of GANX is -76.87% as on 9 Oct '26.

What is the high & low stock price of GANX today?

chevron-up
GANX stock price hit a high of $1.64 and low of $1.61 as of 9 Oct '26.

Can I buy GANX shares in India?

chevron-up
Yes. You can buy GANX in India by opening an international trading account.